Prescription RequiredRamucirumab is a targeted monoclonal antibody used to treat selected advanced cancers, usually after previous treatment has stopped working or is no longer suitable. It is administered by intravenous infusion and may be used alone or with other cancer medicines.
| Generic Name | Ramucirumab |
| Strength | 500 mg |
| Manufacturer | Eli Lilly and Company |
| Packing | 1 vial |
| Prescribed For | Gastric cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Ramucirumab attaches to vascular endothelial growth factor receptor 2, or VEGFR-2. By blocking this receptor, it prevents tumours from developing new blood vessels. Reducing their blood and nutrient supply can slow cancer growth and spread.
Ramucirumab prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
